Allen C. Ho, MD,
is editor of The Panretinal View. He is a member of the Retina Service, Wills Eye Hospital, and is associate professor of
ophthalmology, Thomas Jefferson University Hospital, Philadelphia.
MCO-010 optogenetic gene therapy for severe vision loss in Stargardt disease
A mutation-agnostic optogenetic gene therapy is in development using multi-characteristic opsin (MCO) to sensitize the retinal bipolar cells to detect light.
Why timing is everything in AMD
2 Clarke Drive Cranbury, NJ 08512